Phase 1/2 studies of DZD8586, a non-covalent BBB penetrant LYN/BTK dual inhibitor, in BTK inhibitor resistant chronic lymphocytic Leukemia (CLL) and other B-cell non-Hodgkin lymphoma (B-NHL) Meeting Abstract


Authors: Song, Y.; Zhou, K.; Jing, H.; Chong, G.; Wu, J.; Liu, W.; Li, Z.; Jiang, M.; Lan, M.; Ding, K.; Cui, G.; Wang, T.; Guo, X.; Gao, S.; Tam, C. S.; Yang, H.; Zhu, F.; Yang, W.; Mi, J. Q.; Su, L.; Fang, K.; Liu, Z.; Roeker, L.; Cheah, C. Y.; Li, J.; Qiu, L. G.
Abstract Title: Phase 1/2 studies of DZD8586, a non-covalent BBB penetrant LYN/BTK dual inhibitor, in BTK inhibitor resistant chronic lymphocytic Leukemia (CLL) and other B-cell non-Hodgkin lymphoma (B-NHL)
Meeting Title: 66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 144
Issue: Suppl. 1
Meeting Dates: 2024 Dec 7-10
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2024-11-05
Start Page: 3248
Language: English
ACCESSION: WOS:001412811900007
DOI: 10.1182/blood-2024-197877
PROVIDER: wos
Notes: Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lindsey Elizabeth Roeker
    143 Roeker